GUANABENZ ACETATE
Clinical safety rating
cautionComprehensive clinical and safety monograph for GUANABENZ ACETATE (GUANABENZ ACETATE).
Central alpha-2 adrenergic agonist; reduces sympathetic outflow from the brainstem, decreasing peripheral vascular resistance and heart rate.
| Metabolism | Primarily hepatic via glucuronidation and oxidation; CYP450 involvement minimal. |
| Excretion | Renal: ~75% as unchanged drug and metabolites; biliary/fecal: ~25%. |
| Half-life | Terminal elimination half-life is 7-12 hours; requires twice-daily dosing for stable antihypertensive effect. |
| Protein binding | Approximately 90% bound to albumin and α1-acid glycoprotein. |
| Volume of Distribution | 2-3 L/kg, indicating extensive tissue distribution. |
| Bioavailability | Oral: ~85% (well absorbed, minimal first-pass metabolism). |
| Onset of Action | Oral: 30-60 minutes. |
| Duration of Action | 6-12 hours; clinical effect may persist for up to 24 hours with chronic dosing due to long half-life. |
| Molecular Weight | 291.13 |
4 mg orally twice daily, titrated up to 8-16 mg twice daily; maximum 32 mg twice daily.
| Dosage form | TABLET |
| Renal impairment | GFR 30-59 mL/min: reduce dose by 50%; GFR <30 mL/min: avoid use or use with extreme caution. |
| Liver impairment | Child-Pugh Class A: no adjustment; Class B: reduce dose by 50%; Class C: avoid use. |
| Pediatric use | Not recommended; safety and efficacy not established in children. |
| Geriatric use | Initiate at lower dose (2 mg twice daily) and titrate slowly due to increased risk of orthostatic hypotension and sedation. |
| 1st trimester | Avoid use in first trimester. Guanabenz crosses the placenta and animal studies have shown teratogenic effects. Human data are limited but risk cannot be excluded. |
| 2nd trimester | Use only if potential benefit justifies risk. May cause fetal bradycardia and hypotension. Avoid near term. |
| 3rd trimester | Avoid use in third trimester due to risk of neonatal hypotension, bradycardia, and withdrawal symptoms. |
Clinical note
Comprehensive clinical and safety monograph for GUANABENZ ACETATE (GUANABENZ ACETATE).
| Placental transfer | Guanabenz crosses the placenta; fetal plasma levels approximately 50-70% of maternal levels based on animal data. |
| Breastfeeding | Guanabenz is excreted into breast milk in small amounts. Caution should be exercised as effects on the nursing infant are unknown. Monitor infant for potential hypotension, sedation, and feeding difficulties. |
| Lactation Rating | L3 (Moderately Safe) |
| Teratogenic Risk | First trimester: Limited human data; animal studies show no teratogenicity at clinically relevant doses. Second and third trimesters: Risk of fetal bradycardia, hypotension, and decreased placental perfusion due to alpha-2 agonist activity. Avoid use unless benefit outweighs risk. |
| Fetal Monitoring | Monitor maternal blood pressure and heart rate. Fetal heart rate monitoring after maternal dosing. Assess for signs of neonatal withdrawal (e.g., irritability, poor feeding) postpartum. |
| Fertility Effects | No evidence of adverse effects on fertility in animal studies or human data. Reversible hyperprolactinemia reported, which may impair fertility. |
■ FDA Black Box Warning
None
| Serious Effects |
Hypersensitivity to guanabenz or any component of the formulationConcurrent use with monoamine oxidase inhibitors (MAOIs)
| Precautions | Rebound hypertension upon abrupt discontinuation; sedation; orthostatic hypotension; syncope; use caution in hepatic impairment. |
| Food/Dietary | No significant food interactions reported. Avoid excessive alcohol intake, as it may enhance the hypotensive and sedative effects. |
| Clinical Pearls | Guanabenz is a centrally acting alpha-2 agonist similar to clonidine. Abrupt discontinuation can cause rebound hypertension. It may cause dry mouth, sedation, and dizziness. Use with caution in patients with severe coronary insufficiency, recent myocardial infarction, or cerebrovascular disease. Monitor blood pressure regularly. Tolerance may develop with long-term use. |
| Patient Advice | Take guanabenz exactly as prescribed. Do not stop suddenly without consulting your doctor, as this can cause a dangerous rise in blood pressure. · This medication may cause drowsiness or dizziness. Avoid driving or operating machinery until you know how it affects you. · Avoid alcohol and other central nervous system depressants (e.g., sedatives, tranquilizers) as they may increase sedation. · Dry mouth is common; suck on sugarless candy or ice chips to relieve discomfort. · Notify your doctor if you experience slow heartbeat, fainting, or swelling in your feet or legs. · Weigh yourself regularly and report rapid weight gain to your doctor. · Do not use over-the-counter cough, cold, or allergy products unless approved by your doctor, as they may contain ingredients that affect blood pressure. |
Loading safety data…